Company Description
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.
It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions.
The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells.
It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
| Country | United States |
| Founded | 1989 |
| IPO Date | Jan 21, 1997 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 86 |
| CEO | David I. Portnoy |
Contact Details
Address: 700 Brooker Creek Boulevard, Suite 1800 Oldsmar, Florida 34677 United States | |
| Phone | 813 749 2100 |
| Website | cryo-cell.com |
Stock Details
| Ticker Symbol | CCEL |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | December - November |
| Reporting Currency | USD |
| CIK Code | 0000862692 |
| CUSIP Number | 228895108 |
| ISIN Number | US2288951088 |
| Employer ID | 22-3023093 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Mark L. Portnoy | Co-Chief Executive Officer and Director |
| David I. Portnoy | Chairman and Co-Chief Executive Officer |
| Jill M. Taymans | Chief Financial Officer and Vice President of Finance |
| Oleg Mikulinsky | Chief Information Officer |
| Dr. Joanne Kurtzberg M.D. | Medical Director and Member of Medical and Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 15, 2025 | 10-Q | Quarterly Report |
| May 22, 2025 | 8-K | Current Report |
| May 8, 2025 | 8-K | Current Report |
| Apr 14, 2025 | 10-Q | Quarterly Report |
| Feb 28, 2025 | 10-K | Annual Report |
| Dec 27, 2024 | SCHEDULE 13G | Filing |
| Nov 12, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 17, 2024 | 10-Q/A | [Amend] Quarterly report |